Trial intelligence / Profile preview

First trimester miscarriage: misoprostol alone versus mifepristone + misoprostol

ACTRN12612001254886Phase 4Terminated

Sponsor
Nandini Somanathan
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of mifepristone and misoprostol in miscarriage (2 arms), sponsored by Nandini Somanathan. Primary endpoints: Need for surgical uterine curettage and Need for repeat dose of misoprostol. Started Feb 2015; status: terminated.

02

Drugs

mifepristonemisoprostol
03

Conditions

miscarriage

Beyond the preview

Go deeper on ACTRN12612001254886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612001254886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call